Forteo is a bone-forming drug whose active ingredient is teriparatide.
This injectable drug is indicated for the treatment of osteoporosis because its action regulates the metabolism of calcium and phosphate in the bones, promoting a new and stronger bone structure.
- Forteo is indicated for the treatment of osteoporosis.
- A disease that makes bones more fragile and thin.
- For the treatment of osteoporosis associated with systemic corticosteroid therapy.
- Both in men and women.
- And for the treatment of osteoporosis with high risk of fractures in both cases.
- Postmenopausal women as well as men; High-risk osteoporosis includes a history of osteoporotic fractures.
- Or the presence of multiple risk factors for fractures.
- Or the failure of osteoporosis treatment before a medical decision.
A 3 ml bottle of Forteo containing an injector pen for application costs around 2800 reais.
Inject 20 mcg, once a day, subcutaneously
Forteo may cause angina; high pressure; skin rash; constipation; Diarrhea; nausea; vomiting increased calcium in the blood; leg cramps; dental changes; joint pain; torticollis; weakness; increased coughing; difficulty breathing pharyngitis; rhinitis; pneumonia; depression; Headache; insomnia; fainting; dizziness; fear of heights; Sweats.
Risk of pregnancy C; Women who breastfeed; Hypersensitivity to one of the components of the formula.